Bahrain second country in the world to approve Pfizer/BioNTech COVID-19 vaccine

China's Sinopharm vaccine already granted Bahrain's approval

Syringes are seen in front of displayed Biontech and Pfizer logos in this illustration taken November 10, 2020.

Syringes are seen in front of displayed Biontech and Pfizer logos in this illustration taken November 10, 2020.

REUTERS/Dado Ruvic/Illustration
MANAMA — Bahrain’s approval of the Pfizer/BioNTech coronavirus vaccine makes the kingdom the second country in the world to grant an Emergency Use Authorisation (EUA) for the vaccine.

The confirmation of approval by the National Health Regulatory Authority (NHRA) of Bahrain, followed thorough analysis and review undertaken by the authority of all available data. It is Bahrain’s second approval of a COVID-19 vaccine EUA, following the kingdom’s approval in November of the Sinopharm vaccine for use by frontline workers.

Bahrain’s comprehensive “Test, Trace and Treat” COVID-19 response strategy, with one of the highest testing rates per capita in the world, has proved effective in breaking the chains of infection, managing down case numbers, and saving lives.

Dr. Mariam Al Jalahma, CEO of NHRA commented: “The approval of the Pfizer/BioNTech vaccine will add a further important layer to the Kingdom’s national COVID-19 response, which has strongly prioritized protecting the health of all citizens and residents during the pandemic.”

Lindsey Dietschi, Pfizer Gulf Cluster Lead said: “Today’s Emergency Use Authorization in the Kingdom of Bahrain marks a historic moment in the fight against COVID-19."

"This authorization is a goal we have been working toward since we first declared that science will win, and we applaud the National Health Regulatory Authority in the kingdom of Bahrain for their ability to conduct a careful assessment and take timely action to help protect the people of Bahrain.”


© Copyright 2020 The Saudi Gazette. All Rights Reserved. Provided by SyndiGate Media Inc. (

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

More From Health